Deliver Your News to the World

CybeRelease: (OTC: BSLM) Gearing up for 2007


(CybeRelease, December 19, 2006) - Lake Harmony - Bio Solutions Manufacturing, Inc. (OTC BB: BSLM; Frankfurt: B2T.F) has completed a number of strategic partnerships and a significant acquisition to provide an integrated solution to the twin problems of grease buildups and imports of petroleum-based diesel. According to a recent published report, brown and black grease is clogging sewers nationwide and the cost of keeping them open - at the expense of local taxpayers - is over $25 billion per annum.

Bio Solutions Manufacturing has acquired an oil and grease extraction technology for the removal of fat, oil, and grease from organic waste effluent. The patent pending technology - called a Bio-Extractor - is used to isolate the grease in order to deliver it cost-effectively to a bio-conversion plant as feedstock to produce B100 Bio-Diesel fuel. The key advantages to municipalities and landfill sites are: increased sources of ’tipping fee" revenues, reduced costs of disposal and secure, available, cost-effective supplies of cleaner bio-diesel fuel for trucks, buses, power generation and heating.

In the last quarter, the company has hired a marketing and sales staff to spread the message along the Eastern Seaboard and is in the process of negotiating for two pilot sites to be installed during the first quarter of 2007. The pilot sites are “right-sized” and modular, so they can expand their capacity in line with scheduled deliveries of brown and black grease feedstock. “We expect our pilot sites to be profitable showpieces that will be of interest to municipalities, ’closed loop’ environments such as prisons and military bases, in addition to commercial landfill and trucking companies,” said Mr. David Bennett, CEO and President of Bio Solutions Manufacturing, Inc.

To read the complete release, go to

For a Free Newsletter and more information, go to

CybeRelease Gainers are Arotech Corporation (Nasdaq: ARTX), Cadiz, Inc. (Nasdaq: CDZI), Allied HealthCare International Inc. (Nasdaq: AHCI), Simclar, Inc. (Nasdaq: SIMC), Point.360 (Nasdaq: PTSX), Regent Communications, Inc. (Nasdaq: RGCI), SkyePharma PLC (Nasdaq: SKYE) and Manatron, Inc. (Nasdaq: MANA).

CybeRelease Decliners are Bruker BioSciences Corporation (Nasdaq: BRKR), DayStar Technologies, Inc. (Nasdaq: DSTI), Dawson Geophysical Company (Nasdaq: DWSN), Sequenom, Inc. (Nasdaq: SQNM), Matria Healthcare, Inc. (Nasdaq: MATR), Delta Petroleum Corporation (Nasdaq: DPTR), Imax Corporation (Nasdaq: IMAX) and Cogent, Inc. (Nasdaq: COGT).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.